D. Ganea

D. Ganea, R. Hart, C. Liu, 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

IFN-β Inhibits Dendritic Cell Migration through STAT-1–Mediated Transcriptional Suppression of CCR7 and Matrix Metalloproteinase 9

D. Ganea, J. Yen, W. Kong, 2010, The Journal of Immunology.

Neuropeptides: keeping the balance between pathogen immunity and immune tolerance.

E. González-Rey, M. Delgado, D. Ganea, 2010, Current opinion in pharmacology.

Galanin down-regulates microglial tumor necrosis factor-α production by a post-transcriptional mechanism

D. Ganea, Yaming Su, G. Jonakait, 2003, Journal of Neuroimmunology.

Vasoactive intestinal peptide inhibits IL-8 production in human monocytes by downregulating nuclear factor kappaB-dependent transcriptional activity.

M. Delgado, D. Ganea, Mario Delgado, 2003, Biochemical and biophysical research communications.

Vasoactive intestinal peptide inhibits IL-8 production in human monocytes.

M. Delgado, D. Ganea, M. Delgadoa, 2003, Biochemical and biophysical research communications.

Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.

R. Tuma, D. Ganea, W. Kong, 2014, Cellular immunology.

Higher susceptibility to experimental autoimmune encephalomyelitis in Muc1-deficient mice is associated with increased Th1/Th17 responses

D. Ganea, Y. Park, J. Yen, 2013, Brain, Behavior, and Immunity.

Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis

D. Ganea, J. Yen, W. Kong, 2011, Brain, Behavior, and Immunity.

Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity.

M. Delgado, D. Ganea, 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP.

M. Delgado, D. Ganea, M. Delgado, 2001, Archivum immunologiae et therapiae experimentalis.

Macrophages : In Vitro and In Vivo Studies Enhance IL-10 Production by Murine Adenylate Cyclase-Activating Polypeptide Vasoactive Intestinal Peptide and Pituitary and Doina Ganea

E. Muñoz-Elías, M. Delgado, D. Ganea, 1999 .

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.

E. Muñoz-Elías, M. Delgado, D. Ganea, 1999, Journal of immunology.

Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.

A. Chorny, E. González-Rey, M. Delgado, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide promote in vivo generation of memory Th2 cells

M. Delgado, J. Leceta, D. Ganea, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

VIP and PACAP Induce Shift to a Th2 Response by Upregulating B7.2 Expression

M. Delgado, J. Leceta, D. Ganea, 2000, Annals of the New York Academy of Sciences.

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression.

M. Delgado, J. Leceta, D. Ganea, 1999, Journal of immunology.

Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs.

M. Delgado, D. Ganea, Mario Skarica, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

In Vitro Differentiation of Dendritic Cells in the Presence of Prostaglandin E2 Alters the IL-12/IL-23 Balance and Promotes Differentiation of Th17 Cells1

D. Ganea, Huie Jing, J. Yen, 2008, The Journal of Immunology.

Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family

D. Ganea, J. Yen, M. Toscano, 2010, Lipids in Health and Disease.

Inhibition of Endotoxin-Induced Macrophage Chemokine Production by Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide In Vitro and In Vivo1

M. Delgado, D. Ganea, Doina Ganea, 2001, The Journal of Immunology.

Cyclase-Activating Polypeptide In Vitro and Intestinal Peptide and Pituitary Adenylate Chemokine Production by Vasoactive Inhibition of Endotoxin-Induced Macrophage

M. Delgado, D. Ganea, 2001 .

In vitro stimulatory effect of substance P on hematopoiesis.

P. Rameshwar, D. Ganea, P. Gascón, 1993, Blood.

Prostaglandin E2 Induces Matrix Metalloproteinase 9 Expression in Dendritic Cells through Two Independent Signaling Pathways Leading to Activator Protein 1 (AP-1) Activation

D. Ganea, Huie Jing, J. Yen, 2011, The Journal of Biological Chemistry.

Bone Marrow-Derived Dendritic Cells Generated in the Presence of Resolvin E1 Induce Apoptosis of Activated CD4+ T Cells1

D. Ganea, James H Tadros, E. Vassiliou, 2008, The Journal of Immunology.

Induce Apoptosis of Activated CD 4 Generated in the Presence of Resolvin E 1 Bone Marrow-Derived Dendritic Cells

D. Ganea, James H Tadros, E. Vassiliou, 2008 .

Members of the novel UBASH3/STS/TULA family of cellular regulators suppress T‐cell‐driven inflammatory responses in vivo

D. Ganea, E. Liverani, S. Kunapuli, 2014, Immunology and cell biology.

Apoptosis and the Immune Response

D. Ganea, C. Gregory, 1996 .

Unique Effects of Compounds Active at Both Cannabinoid and Serotonin Receptors During Stroke

R. Tuma, D. Ganea, A. Mahadevan, 2012, Translational Stroke Research.

CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury.

J. Jallo, R. Tuma, M. Adler, 2009, Microvascular research.

Prostaglandin E2 inhibits Tr1 cell differentiation through suppression of c-Maf

D. Ganea, W. Kong, K. Hooper, 2017, PloS one.

Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs.

D. Ganea, 1996, Advances in neuroimmunology.

Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex

D. Ganea, Hao Tang, Hao Tang, 1994, Journal of Neuroimmunology.

Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury.

R. Tuma, D. Ganea, J. Heller, 2011, Journal of neurotrauma.

Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD 4 and CD 8 regulatory T cells

A. Chorny, E. González-Rey, M. Delgado, 2006 .

Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.

A. Chorny, E. González-Rey, M. Delgado, 2006, Blood.

CellsPeptide Generates Tolerogenic Dendritic The Neuropeptide Vasoactive Intestinal

E. González-Rey, M. Delgado, D. Ganea, 2005 .

The Neuropeptide Vasoactive Intestinal Peptide Generates Tolerogenic Dendritic Cells1

E. González-Rey, M. Delgado, D. Ganea, 2005, The Journal of Immunology.

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Young Hak Kim, N. Reinmuth, A. Chiang, 2019, The Lancet.

Vasoactive intestinal peptide inhibits cytokine production in T lymphocytes through cAMP-dependent and cAMP-independent mechanisms

I. Gozes, D. Ganea, D. Brenneman, 1999, Regulatory Peptides.

Vasoactive Intestinal Peptide Stimulates p59fyn Kinase Activity in Murine Thymocytes

Lei Sun, D. Ganea, Z. Xin, 1997, Peptides.

Effect of vasoactive intestinal peptide (VIP) on cytokine production and expression of VIP receptors in thymocyte subsets

D. Ganea, T. Denny, B. Dittel, 1997, Regulatory Peptides.

Cutting Edge: Is Vasoactive Intestinal Peptide a Type 2 Cytokine?

M. Delgado, D. Ganea, 2001, The Journal of Immunology.

Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis

A. Chorny, E. González-Rey, M. Delgado, 2006, European journal of immunology.

Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo

A. Chorny, E. González-Rey, M. Delgado, 2005, Journal of leukocyte biology.

Vasoactive intestinal peptide generates CD4CD25 regulatory T cells in vivo

A. Chorny, E. González-Rey, M. Delgado, 2005 .

The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation

D. Ganea, W. Kong, K. Hooper, 2016, Brain, Behavior, and Immunity.

Interferon (cid:1) induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation

D. Ganea, J. Yen, 2009 .

Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells.

D. Ganea, Huie Jing, E. Vassiliou, 2003, Cellular immunology.

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Nuclear Factor-κB-dependent Gene Activation at Multiple Levels in the Human Monocytic Cell Line THP-1*

M. Delgado, D. Ganea, 2001, The Journal of Biological Chemistry.

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1.

M. Delgado, D. Ganea, 2001, The Journal of biological chemistry.

Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response.

A. Chorny, E. González-Rey, M. Delgado, 2006, Blood.

VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells

E. González-Rey, M. Delgado, D. Ganea, 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4+ T cells

M. Delgado, D. Ganea, Vikas Sharma, 2004, Journal of leukocyte biology.

VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cells

E. Muñoz-Elías, M. Delgado, D. Ganea, 1999, Journal of Neuroimmunology.

Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide modulate endotoxin‐induced IL‐6 production by murine peritoneal macrophages

D. Pozo, M. Delgado, C. Martínez, 1998, Journal of leukocyte biology.

The cytokine network type I IFN‐IL‐27‐IL‐10 is augmented in murine and human lupus

D. Ganea, R. Caricchio, S. Gallucci, 2019, Journal of leukocyte biology.

Neuropeptide regulation of cytokine expression: effects of VIP and Ro 25-1553.

D. Ganea, A. Welton, Hao Tang, 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophages

M. Delgado, D. Ganea, 2000, Journal of Neuroimmunology.

Differentiation of Th 17 Cells IL-12 / IL-23 Balance and Promotes Alters the 2 the Presence of Prostaglandin E In Vitro Differentiation of Dendritic Cells in Ganea

D. Ganea, Huie Jing, J. Yen, 2008 .

VIP Prevents Experimental Multiple Sclerosis by Downregulating Both Inflammatory and Autoimmune Components of the Disease

Javier Martín, D. Pozo, A. Chorny, 2006, Annals of the New York Academy of Sciences.

Vasoactive Intestinal Peptide Generates CD4+CD25+ Regulatory T Cells in vivo

A. Chorny, E. González-Rey, M. Delgado, 2006, Annals of the New York Academy of Sciences.

VIP and PACAP Enhance the In Vivo Generation of Memory TH2 Cells by Inhibiting Peripheral Deletion of Antigen-Specific Effectors

M. Delgado, D. Ganea, 2001, Archives of physiology and biochemistry.

Regulation of VIP production and secretion by murine lymphocytes

M. Delgado, C. Martínez, J. Leceta, 1999, Journal of Neuroimmunology.

VIP and PACAP down-regulate CXCL10 (IP-10) and up-regulate CCL22 (MDC) in spleen cells

D. Ganea, Huie Jing, Xiuju Jiang, 2002, Journal of Neuroimmunology.

PACAP in Immunity and Inflammation

M. Delgado, C. Martínez, J. Leceta, 2003, Annals of the New York Academy of Sciences.

Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions

M. Delgado, D. Ganea, 2011, Amino Acids.

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase- Activating Polypeptide Inhibit the Production of Inflammatory Mediators by Activated Microglia

M. Delgado, J. Leceta, D. Ganea, 2022 .

Role of Neuropeptides in T-Cell Differentiation

M. Delgado, D. Ganea, 2004 .

Peptide a Type 2 Cytokine? Cutting Edge: Is Vasoactive Intestinal

M. Delgado, D. Ganea, 2001 .

Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression.

R. Tuma, D. Ganea, J. Yen, 2012, Blood.

This information is current as Inhibiting Fas Ligand Expression Inhibit T Cell-Mediated Cytotoxicity by Adenylate Cyclase-Activating Polypeptide Vasoactive Intestinal Peptide and Pituitary

M. Delgado, D. Ganea, 2017 .

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit T Cell-Mediated Cytotoxicity by Inhibiting Fas Ligand Expression1

M. Delgado, D. Ganea, Doina Ganea, 2000, The Journal of Immunology.

Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFNγ from stimulated murine T lymphocytes

D. Ganea, S. Lei, 1993, Journal of Neuroimmunology.

Protein tyrosine phosphatase σ regulates autoimmune encephalomyelitis development

R. Hussain, M. Tremblay, Shuxin Li, 2017, Brain, Behavior, and Immunity.

VIP and PACAP inhibit Fas ligand-mediated bystander lysis by CD4+ T cells

M. Delgado, D. Ganea, 2001, Journal of Neuroimmunology.

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit Antigen-Induced Apoptosis of Mature T Lymphocytes by Inhibiting Fas Ligand Expression1

M. Delgado, D. Ganea, 2000, The Journal of Immunology.

Vasoactive Intestinal Peptide: Immune Mediator and Potential Therapeutic Agent

M. Delgado, D. Ganea, 2012 .

Anti‐inflammatory Actions of VIP/PACAP: Role in Endotoxemia

M. Delgado, C. Martínez, J. Leceta, 2000, Annals of the New York Academy of Sciences.

VIP and PACAP38 Modulate Cytokine and Nitric Oxide Production in Peritoneal Macrophages and Macrophage Cell Lines

E. Muñoz-Elías, M. Delgado, C. Martínez, 1999, Annals of the New York Academy of Sciences.

VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression.

M. Delgado, J. Leceta, D. Ganea, 1999, Journal of immunology.

Modulation of B7.1 and B7.2 Expression Activated Macrophages Through the Costimulatory Activity of Resting and VIP and PACAP Differentially Regulate the

M. Delgado, J. Leceta, D. Ganea, 1999 .

Studiesby Macrophages : In Vitro and In Vivo Production α Inhibit Endotoxin-Induced TNF-Adenylate Cyclase-Activating Polypeptide Vasoactive Intestinal Peptide and Pituitary

D. Pozo, M. Delgado, C. Martínez, 1999 .

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit Endotoxin-Induced TNF-a Production by Macrophages : In Vitro and In Vivo Studies 1

D. Pozo, M. Delgado, C. Martínez, 1999 .

Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes

M. Delgado, C. Martínez, D. Ganea, 1996, Journal of Neuroimmunology.

Transcription in Macrophages by Inhibiting Prevent Inducible Nitric Oxide Synthase Adenylate Cyclase-Activating Polypeptide Vasoactive Intestinal Peptide and Pituitary

E. Muñoz-Elías, M. Delgado, D. Ganea, 1999 .

Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1

D. Ganea, J. Yen, A. Gamero, 2017, The Journal of Immunology.

VIP and PACAP Inhibit Activation Induced Apoptosis in T Lymphocytes

M. Delgado, D. Ganea, 2000, Annals of the New York Academy of Sciences.

Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.

D. Pozo, M. Delgado, C. Martínez, 1999, Journal of immunology.

Prostaglandin E2-induced IL-23p19 Subunit Is Regulated by cAMP-responsive Element-binding Protein and C/AATT Enhancer-binding Protein β in Bone Marrow-derived Dendritic Cells*

D. Ganea, J. Yen, M. Toscano, 2012, The Journal of Biological Chemistry.

Prostaglandin E 2 inhibition of IL-27 production in murine dendritic cells : a novel mechanism which involves IRF 1

D. Ganea, J. Yen, Ping-chang Kuo, 2017 .

Immunoregulatory effects of neuropeptides. Stimulation of interleukin-2 production by substance P

P. Rameshwar, D. Ganea, P. Gascón, 1992, Journal of Neuroimmunology.

Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor.

P. Rameshwar, D. Ganea, T. Denny, 2002, Experimental hematology.

Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA

M. Delgado, C. Martínez, D. Ganea, 1996, Journal of Neuroimmunology.

Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex

Lei Sun, D. Ganea, 1993, Journal of Neuroimmunology.

IFN-b Inhibits Dendritic Cell Migration through STAT-1–Mediated Transcriptional Suppression of CCR7 and Matrix Metalloproteinase 9

D. Ganea, 2010 .

Vasoactive Intestinal Peptide

E. González-Rey, M. Delgado, D. Ganea, 2006, Annals of the New York Academy of Sciences.

Overall survival results from a phase III trial of trifluridine/tipiracil versus placebo in patients with metastatic gastric cancer refractory to standard therapies (TAGS).

G. Beretta, J. Tabernero, M. Alsina, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Acute Down‐Regulation of Antibody Production Following Spinal Cord Injury: Role of Systemic Catecholamines

D. Ganea, J. Vega, 2003, Journal of neuropathology and experimental neurology.

The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases

D. Ganea, W. Kong, K. Hooper, 2015, Acta physiologica.

The Significance of Vasoactive Intestinal Peptide in Immunomodulation

D. Pozo, M. Delgado, D. Ganea, 2004, Pharmacological Reviews.

Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions

M. Delgado, D. Ganea, 2013, Amino Acids.

Inhibition of IFN-γ-Induced Janus Kinase-1-STAT1 Activation in Macrophages by Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide

M. Delgado, D. Ganea, 2000, The Journal of Immunology.

A novel VIP signaling pathway in T cells cAMP→protein tyrosine phosphatase (SHP-2?)→JAK2/STAT4→Th1 differentiation

Li Liu, D. Ganea, J. Yen, 2007, Peptides.

Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses.

Javier Martín, D. Pozo, A. Chorny, 2006, The American journal of pathology.

Granzyme B, a new player in activation-induced cell death, is down-regulated by vasoactive intestinal peptide in Th2 but not Th1 effectors

M. Delgado, D. Ganea, V. Sharma, 2006, The Journal of Immunology.

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

David Pozo, Mario Delgado, D. Pozo, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Vasoactive intestinal peptide prevents activated microglia‐induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma

M. Delgado, D. Ganea, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation

M. Delgado, D. Ganea, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity.

M. Delgado, D. Ganea, R. Rodriguez, 2003, Cellular and molecular biology.

Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide inhibit chemokine production in activated microglia

M. Delgado, D. Ganea, G. Jonakait, 2002, Glia.

The neuropeptides VIP and PACAP inhibit IL-2 transcription by decreasing c-Jun and increasing JunB expression in T cells

D. Ganea, Hong-ying Wang, Xiaoming Jiang, 2000, Journal of Neuroimmunology.

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-Jun*

E. Muñoz-Elías, I. Gozes, M. Delgado, 1998, The Journal of Biological Chemistry.

VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: in vitro and in vivo studies 1 The first two authors have contributed equally to the present work. 1

D. Pozo, M. Delgado, C. Martínez, 1998, Journal of Neuroimmunology.

The Effect of Alpha‐fetoprotein on the Immune Reponse: Inhibition of the Humoral Response in Adult Mice Antigenically Stimulated with Sheep Red Blood Cells Suspended in Mouse Amniotic Fluid or Alpha‐fetoprotein

A. Olìnescu, D. Ganea, A. Dumitrescu, 1978 .

Prostaglandin E2 induces IL‐23 production in bone marrow‐derived dendritic cells

D. Ganea, Huie Jing, Doina Ganea, 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The Proinflammatory Effect of Prostaglandin E2 in Experimental Inflammatory Bowel Disease Is Mediated through the IL-23→IL-17 Axis1

R. Tuma, D. Ganea, J. Yen, 2007, The Journal of Immunology.

Inhibitory neuropeptide receptors on macrophages.

M. Delgado, D. Ganea, 2001, Microbes and infection.

Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer.

R. Govindan, K. O'Byrne, P. Postmus, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Interleukin-12 Transcription by Regulating Nuclear Factor κB and Ets Activation*

M. Delgado, D. Ganea, 1999, The Journal of Biological Chemistry.

Microbial Amyloids Induce Interleukin 17A (IL-17A) and IL-22 Responses via Toll-Like Receptor 2 Activation in the Intestinal Mucosa

D. Ganea, J. Yen, R. Tsolis, 2012, Infection and Immunity.

VIP Protects Th2 Cells by Downregulating Granzyme B Expression

M. Delgado, D. Ganea, Vikas Sharma, 2006, Annals of the New York Academy of Sciences.

Granzyme B, a New Player in Activation-Induced Cell Death, Is Down-Regulated by Vasoactive Intestinal Peptide in Th2 but Not Th1 Effectors1

M. Delgado, D. Ganea, Vikas Sharma, 2006, The Journal of Immunology.

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.

D. Pozo, M. Delgado, C. Martínez, 1999, Journal of immunology.

VIP1 and VIP2 Receptors but not PVR1 Mediate the Effect of VIP/PACAP on Cytokine Production in T Lymphocytes

D. Ganea, Hong-ying Wang, Xiaoming Jiang, 1998, Annals of the New York Academy of Sciences.

A Novel Signaling Pathway Mediates the Inhibition of CCL3/4 Expression by Prostaglandin E2*

D. Ganea, Huie Jing, J. Yen, 2004, Journal of Biological Chemistry.

CHAPTER 5 – Vasoactive Intestinal Peptide: An Anti-inflammatory Neuropeptide

M. Delgado, D. Ganea, 2007 .

TH2 Lymphocytes Secrete Functional VIP upon Antigen Stimulation

M. Delgado, D. Ganea, X. Jiang, 2001, Archives of physiology and biochemistry.

Anti-inflammatory neuropeptides: A new class of endogenous immunoregulatory agents

Mario Delgado, M. Delgado, D. Ganea, 2008, Brain, Behavior, and Immunity.

Down‐regulation of Cytokine Expression in Murine Lymphocytes by PACAP and VIP

D. Ganea, Hao Tang, Z. Xin, 1996, Annals of the New York Academy of Sciences.

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.

M. Delgado, C. Martínez, D. Ganea, 1996, Journal of immunology.

Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins.

P. Rameshwar, D. Ganea, P. Gascón, 1993, Journal of immunology.

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.

E. Muñoz-Elías, M. Delgado, D. Ganea, 1999, Journal of immunology.

Immunomodulation by Vasoactive Intestinal Polypeptide (VIP)

D. Ganea, W. Kong, K. Hooper, 2016 .

Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism.

D. Ganea, H. Tang, H. Y. Wang, 1996, Journal of immunology.

The combination of selective inhibition of the cannabinoid CB1 receptor and activation of the cannabinoid CB2 receptor yields improved attenuation of motor and autonomic deficits in a mouse model of spinal cord injury.

J. Gaughan, J. Jallo, R. Tuma, 2008, Clinical neurosurgery.

Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial

P. Fishman, T. Ciuleanu, A. Croitoru, 2021, Cancers.

Induction of IL-3 and granulocyte-macrophage colony-stimulating factor by substance P in bone marrow cells is partially mediated through the release of IL-1 and IL-6.

P. Rameshwar, D. Ganea, P. Gascón, 1994, Journal of Immunology.

Vasoactive intestinal peptide (VIP) inhibits TGF-β1 production in murine macrophages

M. Delgado, D. Ganea, Wei Sun, 2000, Journal of Neuroimmunology.

PGE2-induced metalloproteinase-9 is essential for dendritic cell migration.

D. Ganea, J. Yen, Tanzilya Khayrullina, 2008, Blood.

Inhibition of microglial CD40 expression by pituitary adenylate cyclase-activating polypeptide is mediated by interleukin-10

D. Ganea, G. Jonakait, Woong-Ki Kim, 2002, Journal of Neuroimmunology.

Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis.

D. Ganea, Doina Ganea, F. Safadi, 2007, Arthritis and rheumatism.

Interferon induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation

D. Ganea, J. Yen, 2009 .

Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells

D. Ganea, Huie Jing, Evros K. Vassiliou, 2003, Journal of leukocyte biology.

Activation B and IFN Regulatory Factor 1 κ NF-Transcription in Macrophages by Inhibiting Prevent Inducible Nitric Oxide Synthase Adenylate Cyclase-Activating Polypeptide Vasoactive Intestinal Peptide and Pituitary and Doina Ganea

E. Muñoz-Elías, M. Delgado, D. Ganea, 1999 .

The effect of protease inhibitors on the polyclonal B cell activator from the serum of patients with rheumatoid arthritis.

D. Ganea, J. Skosey, M. Teodorescu, 1982, International journal of immunopharmacology.

Degradation of a chromogenic substrate by alpha 2-macroglobulin from plasma of patients with rheumatoid arthritis.

D. Ganea, J. Skosey, M. Teodorescu, 1984, Arthritis and rheumatism.

Blast transformation of B cells induced by an alpha-macroglobulin-associated lymphokine produced in crowded lymphoid cell cultures.

D. Ganea, M. Teodorescu, S. Dray, 1983, Journal of immunology.

Polyclonal B-cell activator with esterolytic activity and polyclonal gammopathy induced by allogeneic cells in rabbits.

D. Ganea, M. Teodorescu, S. Dray, 1982, Immunology.

An alpha2-macroglobulin associated factor produced by T lymphocytes which provides polyclonal stimulation of B lymphocytes to maintain the turnover of their surface Ig.

D. Ganea, M. Teodorescu, S. Dray, 1981, Immunology.

PURIFICATION FROM THE SERUM OF PATIENTS WITH RHEUMATOID ARTHRITIS OF A POLYCLONAL B CELL ACTIVATOR WITH ESTERASE ACTIVITY AND OF ITS LOW MOLECULAR WEIGHT INHIBITOR

D. Ganea, J. Skosey, M. Teodorescu, 1982 .

Allogeneic lymphocyte stimulation in rabbits: induction of a low MW inhibitor for trypsin and for a concurrently induced alpha-macroglobulin-proteinase complex.

D. Ganea, M. Teodorescu, S. Dray, 1985, Immunology.

Differential effects of IFN‐β on IL‐12, IL‐23, and IL‐10 expression in TLR‐stimulated dendritic cells

D. Ganea, J. Yen, Ping-chang Kuo, 2015, Journal of leukocyte biology.

Receptors and Transcriptional Factors Involved in the Anti‐Inflammatory Activity of VIP and PACAP

C. Martínez, J. Leceta, D. Ganea, 2000, Annals of the New York Academy of Sciences.

Prostaglandin E2 Promotes the Survival of Bone Marrow-Derived Dendritic Cells1

D. Ganea, Huie Jing, Vikas Sharma, 2004, The Journal of Immunology.

Inhibition of Endotoxin-Induced Macrophage Chemokine Production by VIP and PACAP In Vitro and In Vivo

M. Delgado, D. Ganea, M Delgado, 2001, Archives of physiology and biochemistry.

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit Endotoxin-Induced TNF-α Production by Macrophages: In Vitro and In Vivo Studies

D. Pozo, M. Delgado, C. Martínez, 1999, The Journal of Immunology.

The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice.

Daohai Yu, R. Tuma, D. Ganea, 2018, Cellular immunology.

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit Expression of Fas Ligand in Activated T Lymphocytes by Regulating c-Myc, NF-κB, NF-AT, and Early Growth Factors 2/31

M. Delgado, D. Ganea, Doina Ganea, 2001, The Journal of Immunology.

Cannabinoid CB 2 Receptor Activation Attenuates Motor and Autonomic Function Deficits in a Mouse Model of Spinal Cord Injury

J. Jallo, R. Tuma, M. Adler, 2008 .

Cecal ligation puncture procedure.

D. Ganea, A. Gamero, M. Toscano, 2011, Journal of visualized experiments : JoVE.

Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation

D. Ganea, J. Yen, W. Kong, 2011, Clinical lipidology.

A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice.

R. Tuma, D. Ganea, E. Walker, 2015, Life sciences.

Selective CB2 receptor agonist Gp1a attenuates EAE through modulating CD4 T cell differentiation and immune cell infiltration in the CNS (BA8P.131)

R. Tuma, D. Ganea, W. Kong, 2014, Journal of Immunology.

The neuropeptides VIP/PACAP and T cells: inhibitors or activators?

M. Delgado, D. Ganea, 2003, Current pharmaceutical design.

Multiple sclerosis (PP-038)

D. Arnold, F. Najafi, A. Bar-Or, 2010 .

IL-17 Axis → Disease Is Mediated through the IL-23 in Experimental Inflammatory Bowel 2 E The Proinflammatory Effect of Prostaglandin

R. Tuma, D. Ganea, J. Yen, 2007 .

Cannabinoid CB2 receptor activation attenuates motor and autonomic function deficits in a mouse model of spinal cord injury.

J. Jallo, R. Tuma, M. Adler, 2007, Clinical neurosurgery.

Vasoactive Intestinal Polypeptide Induces Regulatory Dendritic Cells That Prevent Acute Graft Versus Host Disease and Leukemia Relapse after Bone Marrow Transplantation

A. Chorny, E. González-Rey, M. Delgado, 2006, Annals of the New York Academy of Sciences.

Neuropeptides: Active participants in regulation of immune responses in the CNS and periphery

D. Ganea, 2008, Brain, Behavior, and Immunity.

Vasoactive intestinal peptide inhibits cytokine production in T lymphocytes through cAMP-dependent and cAMP-independent mechanisms

I. Gozes, D. Ganea, D. Brenneman, 1999, Regulatory Peptides.

Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex.

D. Ganea, H. Tang, Z. Xin, 1994, Journal of neuroimmunology.

Peptide in Th2 but Not Th1 Effectors Down-Regulated by Vasoactive Intestinal Activation-Induced Cell Death, Is Granzyme B, a New Player in

D. Ganea, M. Delgado, Vikas Sharma, 2005 .

Prostaglandin E2-Induced IL-23p19 is regulated by CREB and C/EBPβ in Bone Marrow Derived Dendritic Cells

D. Ganea, J. Yen, M. Toscano, 2012 .

Expression of NK-1 receptor mRNA in murine T lymphocytes.

D. Ganea, R. McCormack, Ronald P. Hart, 1996, Neuroimmunomodulation.

Unique Effects of Compounds Active at Both Cannabinoid and Serotonin Receptors During Stroke

R. Tuma, D. Ganea, A. Mahadevan, 2012, Translational Stroke Research.

ImmunoBiology: The Immune System in Health and Diseases

C. Janeway, P. Travers, D. Ganea, 1996 .

E. Muñoz-Elías, M. Delgado, D. Ganea, 1999, Journal of immunology.

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.

E. Muñoz-Elías, M. Delgado, D. Ganea, 1999, Journal of immunology.

Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels

G. Robledo, E. González-Rey, D. Ganea, 2014, Brain, behavior, and immunity.

Vasoactive intestinal peptide inhibits IL-8 production in human monocytes by downregulating nuclear factor kappaB-dependent transcriptional activity.

D. Ganea, M. Delgado, 2003, Biochemical and biophysical research communications.

Vasoactive intestinal peptide inhibits IL-8 production in human monocytes.

M. Delgado, D. Ganea, 2003, Biochemical and biophysical research communications.

Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer.

R. Govindan, K. O'Byrne, P. Postmus, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunoregulatory effects of neuropeptides. Stimulation of interleukin-2 production by substance P

P. Rameshwar, D. Ganea, P. Gascón, 1992, Journal of Neuroimmunology.

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression.

M. Delgado, J. Leceta, D. Ganea, 1999, Journal of immunology.

Vasoactive Intestinal Peptide (vip) and Pituitary Adenylate Cyclase-activating Polypeptide (pacap) as on Behalf Of: International and American Associations for Dental Research

M. Delgado, D. Ganea, 2022 .

Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes

M. Delgado, C. Martínez, D. Ganea, 1996, Journal of Neuroimmunology.

Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide inhibit the production of inflammatory mediators by activated microglia

M. Delgado, J. Leceta, D. Ganea, 2003, Journal of leukocyte biology.

E. Muñoz-Elías, I. Gozes, M. Delgado, 1998, The Journal of Biological Chemistry.

Repair of single-stranded DNA nicks, gaps, and loops in mammalian cells

R. Kucherlapati, D. Ganea, D. Ayares, 1987, Molecular and cellular biology.

Anti-inflammatory neuropeptides: A new class of endogenous immunoregulatory agents

M. Delgado, D. Ganea, 2008, Brain, Behavior, and Immunity.